US2005171191A1PendingUtilityA1

Anti-first-pass effect compounds

63
Assignee: BIOAVAILABILITY SYSTEMS LLCPriority: Aug 26, 1997Filed: Aug 26, 2004Published: Aug 4, 2005
Est. expiryAug 26, 2017(expired)· nominal 20-yr term from priority
Inventors:James W. Harris
A23L 2/39A23L 33/105C07D 493/10A61K 36/752A61K 31/366A23L 2/06A61K 31/37
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Safe, effective first-pass inhibiting compounds and citrus-derived substances are provided. Formulations containing the compounds are also provided as are methods for their preparation and for inhibiting the first pass effect.

Claims

exact text as granted — not AI-modified
1 . A method of inhibiting the first-pass-effect of a material taken orally by a patient which is subject to the first-pass-effect, comprising the step of co-administering to said patient said material and a compound comprising one of the following cores:  
       
         
           
           
               
               
           
         
       
     
     
         2 - 4 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.